Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review
- PMID: 35098981
- PMCID: PMC8804327
- DOI: 10.14283/jpad.2021.49
Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review
Abstract
Despite older racial and ethnic minorities (REMs) being more likely to develop dementia they are underrepresented in clinical trials focused on neurological disorders. Inclusion of REMs in dementia prevention studies is vital to reducing the impact of disparities in dementia risk. We conducted a systematic review to characterize the number of REM enrolled in brain health and prevention randomized controlled trials (RCTs). RTCs published from January 1, 2004 to April 21, 2020 were included. Participants were normal cognitive adults aged 45 years and older who participated in a Phase II or Phase III U.S. based preventative trial. Analyses were performed to examine differences in trial characteristics between RCTs that did and those that did not report race/ethnicity and to calculate the pooled proportion of each racial/ethnic group in randomized brain healthy prevention trials. A total of 42 studies consisting of 100,748 participants were included in the final analyses. A total of 26 (62%) reported some racial/ethnic identity data. The pooled proportion of REM participants was 0.256 (95% CI, 0.191, 0.326). There is a lack of racial/ethnic reporting of participants and REMs remain underrepresented in brain health prevention RCTs.
Keywords: Alzheimer’s disease; aging; dementia; prevention; underrepresented minorities.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.JAMA Cardiol. 2023 Sep 1;8(9):871-878. doi: 10.1001/jamacardio.2023.2098. JAMA Cardiol. 2023. PMID: 37494015
-
Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.JAMA Oncol. 2023 Feb 1;9(2):180-187. doi: 10.1001/jamaoncol.2022.5511. JAMA Oncol. 2023. PMID: 36416812 Free PMC article.
-
Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review.Cancer. 2022 Nov 1;128(21):3860-3869. doi: 10.1002/cncr.34454. Epub 2022 Sep 15. Cancer. 2022. PMID: 36107740 Free PMC article.
-
Racial and ethnic minority representation in dementia risk factor research: a scoping review of cohort studies.BMJ Open. 2024 Sep 25;14(9):e085592. doi: 10.1136/bmjopen-2024-085592. BMJ Open. 2024. PMID: 39322589 Free PMC article.
-
Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review.JAMA Netw Open. 2019 Nov 1;2(11):e1914745. doi: 10.1001/jamanetworkopen.2019.14745. JAMA Netw Open. 2019. PMID: 31722023 Free PMC article.
Cited by
-
Attitudes and Preferences Towards Screening for Dementia with a Focus on Ethnic Minority and Low Socio-Economic Groups: A Systematic Review of Research Studies Written in the English Language.J Alzheimers Dis. 2024;100(4):1315-1331. doi: 10.3233/JAD-240315. J Alzheimers Dis. 2024. PMID: 39031361 Free PMC article.
-
Operationalising routinely collected patient data in research to further the pursuit of social justice and health equity: a team-based scoping review.BMC Med Res Methodol. 2025 Jan 21;25(1):14. doi: 10.1186/s12874-025-02466-9. BMC Med Res Methodol. 2025. PMID: 39838312 Free PMC article.
-
Development of a Mobile-First Registry to Recruit Healthy Volunteers and Members of Underrepresented Communities for Alzheimer's Disease Prevention Studies.J Prev Alzheimers Dis. 2023;10(4):857-864. doi: 10.14283/jpad.2023.86. J Prev Alzheimers Dis. 2023. PMID: 37874108 Free PMC article.
-
Drug repurposing for Alzheimer's disease and other neurodegenerative disorders.Nat Commun. 2025 Feb 19;16(1):1755. doi: 10.1038/s41467-025-56690-4. Nat Commun. 2025. PMID: 39971900 Free PMC article. Review.
-
A Mindfulness-Based Lifestyle Intervention for Dementia Risk Reduction: Protocol for the My Healthy Brain Feasibility Randomized Controlled Trial.JMIR Res Protoc. 2024 Nov 21;13:e64149. doi: 10.2196/64149. JMIR Res Protoc. 2024. PMID: 39571150 Free PMC article.
References
-
- Association As. Facts and Figures 2021. [Available from: https://www.alz.org/alzheimers-dementia/facts-figures.
-
- Vespa J, Armstrong DM, Medina L. Demographic turning points for the United States: Population projections for 2020 to 2060: US Department of Commerce, Economics and Statistics Administration, US; …; 2018.
-
- Living AfC. 2018 Profile of African Americans Age 65 and Over. Washington DC: U.S. Department of Health and Human Services; 2018.
-
- Living AfC. 2018 Profile of Hispanic Americans Age 65 and Over. Washington DC: U.S. Department of Health and Human Services; 2018.
-
- Burneo JG, Martin R. Reporting race/ethnicity in epilepsy clinical trials. Epilepsy & Behavior. 2004;5(5):743–5. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous